NEXGEL’s (NASDAQ:NXGL – Get Rating) lock-up period will expire on Monday, June 20th. NEXGEL had issued 2,585,000 shares in its initial public offering on December 22nd. The total size of the offering was $14,217,500 based on an initial share price of $5.50. After the end of NEXGEL’s lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.
Separately, Maxim Group cut their price objective on NEXGEL to $5.00 in a research report on Thursday, May 26th.
NASDAQ NXGL opened at $1.52 on Monday. NEXGEL has a 1-year low of $1.38 and a 1-year high of $4.66. The firm has a 50-day moving average price of $1.63.
NEXGEL Company Profile (Get Rating)
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
- Get a free copy of the StockNews.com research report on NEXGEL (NXGL)
- Three Upgrades You Need To Pay Attention Too
- Consider These Dividend-Paying Stocks During Inflationary Times
- MarketBeat: Week in Review 6/6 – 6/10
- NIO (NYSE: NIO) Justifies Recent Rally
- DocuSign (NASDAQ: DOCU) Collapses Back To Square One
Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.